18F-FDG PET hypometabolism patterns reflect clinical heterogeneity in sporadic forms of early-onset Alzheimer's disease

Neurobiol Aging. 2017 Nov:59:184-196. doi: 10.1016/j.neurobiolaging.2017.08.009. Epub 2017 Aug 12.

Abstract

Until now, hypometabolic patterns and their correlations with neuropsychological performance have not been assessed as a function of the various presentations of sporadic early-onset Alzheimer's disease (EOAD). Here, we processed and analyzed the patients' metabolic maps at the vertex and voxel levels by using a nonparametric, permutation method that also regressed out the effects of cortical thickness and gray matter volume, respectively. The hypometabolism patterns in several areas of the brain were significantly correlated with the clinical manifestations. These areas included the paralimbic regions for typical presentations of sporadic EOAD. For atypical presentations, the hypometabolic regions included Broca's and Wernicke's areas and the pulvinar in language forms, bilateral primary and higher processing visual regions (with right predominance) in visuospatial forms, and the bilateral prefrontal cortex in executive forms. Similar hypometabolism patterns were also observed in a correlation analysis of the 18F-FDG PET data versus domain-specific, neuropsychological test scores. These heterogeneities might reflect different underlying pathophysiological processes in particular clinical presentations of sporadic EOAD and should be taken into account in future longitudinal and therapeutic studies.

Keywords: Atrophy regression; Cognition; Metabolism; Nonparametric permutation analysis; Positron emission tomography; Sporadic early-onset Alzheimer's disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / diagnostic imaging*
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Alzheimer Disease / psychology*
  • Atrophy
  • Cerebral Cortex / diagnostic imaging
  • Cerebral Cortex / pathology
  • Cognition*
  • Female
  • Fluorodeoxyglucose F18
  • Gray Matter / diagnostic imaging
  • Gray Matter / pathology
  • Humans
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Organ Size
  • Positron-Emission Tomography*
  • Radiopharmaceuticals

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18